Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05136560

Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

Conditions: Sepsis

Sex: All
Ages: 19 Years – N/A
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 102
Sponsor: CHA University

Location: Bundang CHA hospital Seongnam-si Gyeonggi-do

Summary

The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.

Eligibility Criteria

Inclusion Criteria: * Sepsis defined by Sepsis-3 definition * Initial systolic blood pressure \< 90mmHg or blood lactate level \>2mmol/L Exclusion Criteria: * advanced directive for "Do not resuscitation" * recent systemic administration of glucocorticoid (4 weeks) * recent systemic administration of chemotherapy (4 weeks) * recent systemic administration of immunosuppressant (4 weeks) * expected life less than 90 days * Transferred from other hospital * Sepsis diagnosed 24 hours after ED admission * Use of etomidate in ED * pregnant or on lactation * no informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05136560). StuddyBuddy aggregates publicly available trial information.